Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | FABP7 | O15540 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3470475 | 1.00 | CASP3 (0.57) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL9376602 | 1.00 | CASP3 (0.57) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL6779154 | 1.00 | CASP3 (0.57) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL28946743 | 0.89 | CASP3 (0.49) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL17094815 | 0.89 | CASP3 (0.49) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL178791 | 0.88 | CASP3 (0.60) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL10173305 | 0.88 | CASP3 (0.58) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL120703 | 0.88 | CASP3 (0.60) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL2591012 | 0.88 | CASP3 (0.58) | CASP3KMT2AEPHX2PIN1MDM4 | |
| SCHEMBL13044090 | 0.88 | CASP3 (0.58) | CASP3KMT2AEPHX2PIN1MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306530-B1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20260001881-A1 | COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORS | PRIMETIME LIFE SCIENCES LLC (US) | 2026-01-01 | — | — | US | disclosed |
| CN-119039375-B | Solid phase synthesis method of peptides | 成都圣诺生物多肽科技有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119039375-A | Solid phase synthesis method of peptides | 成都圣诺生物多肽科技有限公司 | 2024-11-29 | — | — | CN | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| CN-118576536-A | Double-response type drug-loaded micelle composite hydrogel and preparation method thereof | 辽宁大学 | 2024-09-03 | — | — | CN | disclosed |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-06 | — | — | US | disclosed |
| CN-117801107-A | Benzazepine derivatives, conjugates containing same and application thereof | 上海迪诺医药科技有限公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-4306530-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2024-01-17 | — | — | EP | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| CN-116744978-A | anti-HER 2 immunoconjugates and uses thereof | 博尔特生物治疗药物有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| WO-2022190486-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | 学校法人中部大学 | 2022-09-15 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| US-11325940-B2 | Certain chemical entities, compositions, and methods | NEUPHARMA, INC. (US) | 2022-05-10 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001881-A1 | COMPOUNDS AND METHODS FOR MODULATION OF G-PROTEIN-COUPLED RECEPTORS | GRK2, ARRB1, GPR3 | CASP3 3485/4885KMT2A 2981/4885EPHX2 972/4885 |
| US-11325940-B2 | Certain chemical entities, compositions, and methods | TP53, VHL, SGMS2 | CASP3 811/4885KMT2A 2329/4885EPHX2 79/4885 |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | VIP, NGLY1, NPR1 | CASP3 3541/4885KMT2A 2279/4885EPHX2 3657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.